Catabasis Pharmaceuticals Inc CATB Valuation Ratios and Share Stats

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Catabasis Pharmaceuticals Inc (CATB)
Catabasis Pharmaceuticals Inc (CATB) Financials

Catabasis Pharmaceuticals Inc (CATB)

8.54

0.00

( 0.00% )

Updated: 18:00:00

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-69.059	-94.186	-90.667	-64.962	-83.599	-222.795	-28.946	-30.04
Return on Equity (%)	-90.627	-133.881	-110.712	-74.419	-97.658	-239.185	-30.178	-31.396
Return on Invested Capital (%)	-81.227	-125.636	-113.612	-77.404	-98.837	-239.572	-31.335	-36.181
Operating Margin (%)	N/A	-5380.4	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	-5472.8	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	1.546	0.499	3.039	2.873	2.025	9.396	8.044	6.698
Earnings Per Share	-1.916	-1.157	-2.25	-2.115	-1.857	-14.974	-1.885	-2.008
Cash Per Share	1.254	0.692	1.33	0.796	1.241	6.646	0.746	4.836
Working Capital Per Share	1.658	0.484	3.022	2.728	1.988	9.363	7.95	6.596
Operating Profit Per Share	N/A	0.021	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-1.916	-1.157	-2.25	-2.115	-1.857	-14.974	-1.885	-2.008
EBITDA Per Share	-1.916	-1.157	-2.25	-2.115	-1.857	-14.974	-1.885	-2.008
Free Cash Flow Per Share	-1.913	-1.168	-2.261	-2.116	-1.856	-13.095	-1.881	-2.008

Liquidity Ratios

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	18.82M	23.65M	11.5M	12.43M	20.08M	13.02M	27.5M	N/A

Key Stats and Ratios

Year End December 30 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	15.75M	27.5M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	309.97M
Price to Earnings Ratio	-4.25
Price to Sales Ratio	0
Price to Cash Ratio	1.77
Price to Book Ratio	1.27
Dividend Yield	-

Share Statistics

Shares Outstanding	36.3M
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-
52 Week High	-
52 Week Low	-

More Ratios Coming Soon!

Catabasis Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions